Journal of Cosmetic Dermatology, 18(3), 728737
Implications for employers: Although almost half of employers stated that they were interested in the potential for compounded GLP-1 medications, according to WTWs 2025 Best Practices in Healthcare Survey, only 7% said they were very interested, and there has been very little employer uptake of compounded medications
Presented for research literature review only Manjn A et al
This work was supported by the National Institutes of Health under award numbers 2R01HL115189, P30DK04056, UE5DK137285, and U24 DK132733, and by the National Clinician Scholars Program at the Duke Clinical and Translational Science Institute
The information was obtained from Ortho Molecular
My cosmetic touch ups last me so much longer